Teradyne director plans $140K stock sale
Rhea-AI Filing Summary
TERADYNE, INC (TER) has a notice under Rule 144 indicating that director Marilyn Matz, through Fidelity Brokerage Services LLC, plans to sell 400 shares of Teradyne common stock on or about September 17, 2026, with an approximate aggregate market value of $140,444. These shares were acquired from Teradyne on May 7, 2021 via Restricted Stock Vesting as compensation.
Positive
- None.
Negative
- None.
Key Figures
Planned shares to be sold: 400 shares
Aggregate market value of planned sale: $140,444
Shares sold July 15, 2026: 1,200 shares
+5 more
8 metrics
Planned shares to be sold
400 shares
Teradyne common stock under Rule 144 for the transaction dated September 17, 2026
Aggregate market value of planned sale
$140,444
Estimated value for 400 Teradyne shares in the planned September 17, 2026 sale
Shares sold July 15, 2026
1,200 shares
Teradyne common stock sold by Marilyn Matz on July 15, 2026
Proceeds July 15, 2026 sale
$427,572
Value of 1,200 Teradyne shares sold on July 15, 2026
Shares sold August 17, 2026
1,200 shares
Teradyne common stock sold by Marilyn Matz on August 17, 2026
Proceeds August 17, 2026 sale
$510,000
Value of 1,200 Teradyne shares sold on August 17, 2026
Shares sold September 15, 2026
800 shares
Teradyne common stock sold by Marilyn Matz on September 15, 2026
Proceeds September 15, 2026 sale
$270,264
Value of 800 Teradyne shares sold on September 15, 2026
Key Terms
Rule 144, Restricted Stock Vesting, attorney-in-fact
3 terms
Rule 144 regulatory
"See the definition of "person" in paragraph (a) of Rule 144."
Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.
Restricted Stock Vesting financial
"Common | 05/07/2021 | Restricted Stock Vesting | Issuer"
Restricted stock vesting is the timetable and conditions under which shares granted to employees or insiders become fully owned and can be sold, typically requiring continued work or meeting performance goals. It matters to investors because large blocks of shares can become tradable at once, which can change share supply and price, and because vesting aligns insiders’ incentives with the company’s long‑term performance—think of it like a timed unlock that both rewards and locks in key people.
attorney-in-fact regulatory
"as attorney-in-fact for Marilyn Matz"
An attorney-in-fact is the person or entity given legal authority through a power of attorney to act on behalf of another for specific tasks, such as signing documents, voting shares, or handling transactions. For investors, this matters because it lets a trusted representative make timely decisions or complete paperwork when the owner cannot, much like handing keys to someone to run errands on your behalf—so checks on scope and limits of that authority are important.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What sale is disclosed for TERADYNE, INC (TER) in this Rule 144 notice?
The notice shows that director Marilyn Matz plans to sell 400 shares of Teradyne common stock, with an approximate aggregate market value of $140,444, in a transaction listed for September 17, 2026 on NASDAQ.
What TER common stock sales has Marilyn Matz made in the past three months?
Disclosed past 3‑month sales are: 1,200 shares on July 15, 2026 for $427,572; 1,200 shares on August 17, 2026 for $510,000; and 800 shares on September 15, 2026 for $270,264.
AI-generated analysis. How Rhea-AI works. Not financial advice.